Sugar Maple Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Sugar Maple Asset Management's ABBV Position: Q3 2026 in Review
Sugar Maple Asset Management reduced its AbbVie (ABBV) stake by 1.6% in Q3 2026, selling an estimated $234K and leaving 55,355 shares worth $14.5M. The position accounts for 8.25% of the portfolio, ranked #2.
Sugar Maple Asset Management first reported a position in ABBV in Q1 2024 and has held it in 11 quarters since. 1,436 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Sugar Maple Asset Management held 55,355 shares of AbbVie worth $14.5M as of Q3 2026.
- Sugar Maple Asset Management sold 914 AbbVie shares in Q3 2026, an estimated $234K.
- AbbVie made up 8.25% of Sugar Maple Asset Management's portfolio in Q3 2026, its #2 holding.
- Sugar Maple Asset Management first reported a position in AbbVie in Q1 2024 and has held it in 11 quarters since.
- 1,436 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Sugar Maple Asset Management's 13F filing for Q3 2026, filed 13 Oct 2026.